IVF Failed — What to Do After a Failed Cycle

The blood draw was done. You waited. The phone rang — and the number was negative. Or the transfer resulted in a very early loss. Or you made it to a positive test, only to lose it in the first weeks.

IVF failure means different things in different situations, but the emotional core is the same: you prepared, you hoped, you invested — and it didn't work. The grief is real, the confusion is real, and the question of what comes next can feel both urgent and completely overwhelming.

The first and most important thing to know: one failed IVF cycle does not predict the outcome of future cycles. SART (Society for Assisted Reproductive Technology) cumulative data consistently shows that patients who continue treatment after a failed first cycle have meaningful ongoing success. The path forward exists — it just requires understanding what happened and what, if anything, should change.

Allow Yourself to Grieve

Before we talk about what to do medically, it is worth acknowledging that nothing has to happen immediately. The protocol review, the second opinion, the next steps — all of that can wait a few days or a week.

A failed IVF cycle is a loss. Whether it was a negative beta hCG, a chemical pregnancy, or a miscarriage, you have lost something real: the embryo, the pregnancy you imagined, the version of your future that felt close. Rushing straight into "what's the plan?" without processing the emotional weight of the experience can lead to burnout and decision fatigue.

RESOLVE: The National Infertility Association offers peer-led support groups, one-on-one peer mentor programs, and a provider directory for mental health professionals who specialize in reproductive health. Using these resources is not weakness — it is good strategy for sustaining the emotional reserves that future treatment cycles will require.

Request a Cycle Review Meeting

After a failed IVF cycle, you are entitled to — and should insist on — a formal cycle review meeting with your reproductive endocrinologist. This is not the same as a phone call from a nurse with your beta results. You need a sit-down (or video) meeting with the physician who supervised your cycle to go through what happened in detail.

What to Cover in a Cycle Review

Stimulation response:

• How many eggs were retrieved? Was this consistent with your AFC and AMH?
• Were there any signs of poor response or over-response (OHSS risk)?
• Was the stimulation protocol appropriate for your ovarian reserve profile?

Egg and embryo quality:

• How many eggs were mature (MII)?
• What was the fertilization rate? (Normal is approximately 70–75% with ICSI)
• What were the day-3 and day-5 embryo grades?
• Did embryos arrest before blastocyst stage? If so, at what stage?

Embryo transfer:

• Was the transfer technically smooth? Any difficulty with catheter placement?
• What was the endometrial lining thickness and pattern on the day of transfer?
• Were progesterone levels adequate on transfer day and through the TWW?

Genetics:

• If PGT-A (preimplantation genetic testing) was performed, how many embryos were euploid (chromosomally normal)?
• If no PGT-A was performed, is it worth adding for the next cycle?

Protocol:

• Was this a fresh transfer or a frozen embryo transfer (FET)?
• What luteal phase support medications were used?
• Were there any cycle abnormalities (premature LH surge, elevated progesterone at trigger)?

Bring a list of questions. Take notes. If you don't understand something, ask the physician to explain it in plain language. This meeting is the foundation of the decision about what changes, if anything, should happen next.

Common Reasons IVF Cycles Fail

Egg Quality

Egg quality is the most fundamental variable in IVF success, and the most difficult to improve. Poor egg quality — usually meaning chromosomally abnormal eggs — is more common with advancing age. After 38, more than half of retrieved eggs may be chromosomally abnormal. By 42, the majority may be aneuploid.

This is why IVF success rates decline so sharply with age even when stimulation and retrieval go well: the eggs themselves carry abnormalities that result in abnormal embryos, failed implantation, or early pregnancy loss. No stimulation protocol change can fully overcome this biological reality, though optimizing the protocol can sometimes improve the yield of usable eggs.

Embryo Quality

Embryo quality is partly a function of egg quality and partly a function of sperm quality. Embryos that arrest early (before blastocyst stage) or develop slowly are less likely to implant successfully. A high rate of early arrest can indicate either egg quality issues, sperm DNA fragmentation problems, or both.

If embryo development was poor, sperm DNA fragmentation testing should be on the agenda for the next consultation — particularly if the male partner is over 40, has had prior failed IVF cycles, or has a known sperm parameter abnormality.

Implantation Failure

Some embryos — even genetically normal, good-quality blastocysts — fail to implant in the uterus. ASRM defines recurrent implantation failure (RIF) as failure to achieve clinical pregnancy after transfer of at least 2–3 high-quality embryos (or euploid embryos). The causes of RIF are an active area of research and include:

• Uterine cavity abnormalities: Polyps, submucosal fibroids, adhesions, or a uterine septum can prevent normal implantation. Even a small polyp can reduce implantation rates significantly.
• Endometrial receptivity: The endometrium has a "window of implantation" — a narrow period when it is primed to accept an embryo. If the embryo is transferred outside this window, implantation may fail.
• Thin endometrial lining: A lining below 7mm is associated with lower implantation rates, though there is no absolute cutoff below which success is impossible.
• Hydrosalpinx: A fluid-filled fallopian tube can leak into the uterine cavity and is toxic to embryos. If a hydrosalpinx is identified, surgical removal of the affected tube (salpingectomy) before the next transfer significantly improves success rates.
• Thrombophilia: Some clotting disorders may contribute to implantation failure, though the evidence for treating them (with blood thinners) is mixed.
• Immune factors: While the science is still developing, some reproductive immunologists believe that certain immune responses to embryos contribute to RIF.

Protocol and Technical Factors

Sometimes failure relates to the specific protocol or technical execution rather than the underlying biology:

• A premature LH surge can compromise egg maturity
• Elevated progesterone at trigger can impair endometrial receptivity in a fresh cycle
• Inadequate luteal phase support can prevent implantation
• Technically difficult transfers can displace embryos

These are addressable with protocol modifications for subsequent cycles.

Trying to Conceive at Home?

If you are between IVF cycles or exploring lower-intervention options alongside treatment, MakeAMom offers reusable at-home insemination kits designed for various needs: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. All ship discreetly without a clinic visit required.

Explore home insemination kits at MakeAMom →

Specific Tests to Consider After Failed IVF

ERA Testing (Endometrial Receptivity Analysis)

The ERA test analyzes a biopsy of the endometrial lining to determine the precise window of implantation — the hours during which the endometrium is most receptive to embryo implantation. The test assigns a "personalized embryo transfer" (pET) time that adjusts when progesterone is started relative to the transfer.

ERA testing is most useful in patients with unexplained implantation failure — particularly those who have failed transfers of euploid (PGT-A tested) embryos. Its clinical utility in unselected IVF patients is debated; a large randomized trial (STAR trial) found that routine ERA testing did not improve outcomes in typical patients. However, in patients with multiple failed euploid transfers, it remains a reasonable investigative step.

Uterine Cavity Reassessment

A hysteroscopy or saline infusion sonohysterography (SIS) should be performed if there is any question about uterine anatomy. These tests are often done as part of the initial workup, but the uterus can change — a new polyp can develop between cycles, and adhesions can form after repeated transfers or procedures.

Sperm DNA Fragmentation

If embryo development was poor or the male partner's sperm quality was borderline, sperm DNA fragmentation (SDF) testing assesses the integrity of the DNA within sperm. High SDF (above 25–30% by TUNEL assay or DFI) is associated with lower fertilization rates, poorer embryo quality, and higher miscarriage rates even when conventional semen analysis results appear normal.

If SDF is elevated, lifestyle modifications (reducing heat exposure, quitting smoking, antioxidant supplementation) can help, and testicular sperm extraction (TESE) — which retrieves sperm directly from the testes, where DNA fragmentation is lower — may improve outcomes.

PGT-A (Preimplantation Genetic Testing)

If you did not use PGT-A in the previous cycle, adding it to the next cycle screens embryos for chromosomal abnormalities before transfer. Transferring a euploid (chromosomally normal) embryo eliminates aneuploidy as a cause of failure. This is particularly valuable for women over 35, for whom a significant proportion of embryos are aneuploid.

See our embryo grading and PGT-A guide for detailed information on how genetic testing works.

When to Change Protocols

Your RE may recommend protocol adjustments based on what the cycle data revealed:

A protocol change is not an admission that the previous approach was wrong — it is evidence-based refinement based on new information.

When to Consider Changing Clinics

There are legitimate reasons to seek care at a different clinic after a failed cycle, and you should not feel guilty about doing so. Consider a second opinion or a transfer of care when:

• You cannot get a substantive explanation of why your cycle failed
• The clinic seems to be using the same protocol without modification despite two or more failures
• SART-reported outcomes for your clinic are significantly below national averages for your age group
• You do not feel heard, respected, or adequately informed
• A second opinion reveals a diagnosis or approach your current clinic has not discussed

Getting a second opinion does not mean starting over from scratch — your cycle records, lab results, and embryo reports can all transfer to a new clinic. Read our guide on how to choose a fertility clinic for what to look for in a program.

The Donor Egg Discussion

After multiple failed IVF cycles — particularly in women over 40 with diminished ovarian reserve — donor egg IVF becomes an increasingly important option to discuss.

Donor egg IVF uses eggs from a young, fertile donor (typically 21–32 years old) rather than the patient's own eggs. Because the success rate of IVF is primarily driven by egg quality (and thus egg age), donor egg cycles achieve live birth rates of 50–65% per transfer regardless of the recipient's age. For women who have not achieved success with multiple own-egg cycles, donor eggs may represent the most efficient path to parenthood.

This is not a conversation that means giving up — it is expanding the options. Many patients who were reluctant to consider donor eggs ultimately find the experience profoundly positive. Genetics is one connection to a child, but pregnancy, birth, nursing, and raising are others.

What Cumulative Success Rates Tell Us

One failed IVF cycle is not the end of the story. SART's cumulative success rate data — which tracks patients through multiple cycles — consistently shows that:

• Many patients who do not succeed in cycle 1 succeed by cycle 2 or 3
• Cumulative success rates after 3 cycles are substantially higher than per-cycle rates
• The probability of success per cycle does not necessarily decrease after one failure; it depends on what was learned and what changed

For example, among women under 35, cumulative live birth rates through 3 IVF cycles may exceed 70–80%, even though per-cycle rates are typically 40–50%. This is why persistence — with the right evaluation and protocol adjustments — matters.

Frequently Asked Questions

Q: Is one failed IVF cycle predictive of future cycles? A: No. SART cumulative data consistently shows that patients who continue treatment after a failed first cycle have meaningful ongoing success. Among women under 35, cumulative live birth rates through 3 IVF cycles may exceed 70–80%, even though per-cycle rates are typically 40–50%. A failed cycle provides information for protocol adjustments, not a final verdict on your chances.

Q: What tests should be done after a failed IVF cycle? A: The specific tests depend on what the cycle data revealed. Common investigations include ERA testing (for unexplained implantation failure after euploid transfers), saline infusion sonohysterography or hysteroscopy (to evaluate the uterine cavity for polyps or adhesions), sperm DNA fragmentation testing (if embryo development was poor), and PGT-A testing on embryos in the next cycle if not previously done.

Q: What is the ERA test and when is it useful? A: The ERA (Endometrial Receptivity Analysis) tests an endometrial biopsy to determine the precise window of implantation — the hours when the endometrium is most receptive. It is most useful for patients with unexplained implantation failure after multiple failed transfers of euploid embryos. A large randomized trial (STAR trial) found routine ERA testing did not improve outcomes in typical patients, so it is best reserved for the recurrent implantation failure population.

Q: When should I consider changing fertility clinics after a failed cycle? A: Consider a second opinion if you cannot get a substantive explanation of why your cycle failed, if the clinic uses the same protocol without modification despite two or more failures, if SART-reported outcomes for your clinic are significantly below national averages for your age group, or if you do not feel adequately informed. Your cycle records and embryo reports can transfer to a new clinic — a second opinion does not mean starting from scratch.

Q: When is donor egg IVF recommended after own-egg failures? A: Donor egg IVF becomes an increasingly important discussion after multiple failed own-egg cycles, particularly for women over 40 with diminished ovarian reserve. Donor egg cycles achieve live birth rates of 50–65% per transfer regardless of the recipient's age, because egg quality from a young donor is the primary determinant of success.

Key Takeaways

• A failed IVF cycle is not a verdict — it is information
• A formal cycle review meeting with your RE is essential before making any decisions about next steps
• The most common causes of failure are egg quality, embryo quality, and implantation factors — all of which can be investigated and sometimes addressed
• Tests like ERA, hysteroscopy, PGT-A, and sperm DNA fragmentation can provide actionable information after failed cycles
• Protocol changes, second opinions, and donor egg discussion are all reasonable and evidence-based responses to failure
• Cumulative success rates across multiple cycles are meaningfully higher than per-cycle rates — the data supports continuing treatment

This article is for informational purposes only and does not constitute medical advice. Please consult a board-certified reproductive endocrinologist for personalized guidance.